Literature DB >> 20811158

Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life.

Przemyslaw Sapieha1, Jean-Sebastien Joyal, José Carlos Rivera, Elsa Kermorvant-Duchemin, Florian Sennlaub, Pierre Hardy, Pierre Lachapelle, Sylvain Chemtob.   

Abstract

Retinopathy of prematurity (ROP) is a major complication of preterm birth. It encompasses a spectrum of pathologies that affect vision, from mild disease that resolves spontaneously to severe disease that causes retinal detachment and subsequent blindness. The pathologies are characterized by an arrest in normal retinal vascular development associated with microvascular degeneration. The resulting ischemia and retinal hypoxia lead to excessive abnormal compensatory blood vessel growth. However, this neovascularization can lead to fibrous scar formation and culminate in retinal detachment. Present therapeutic modalities to limit the adverse consequences of aberrant neovascularization are invasive and/or tissue-destructive. In this Review, we discuss current concepts on retinal microvascular degeneration, neovascularization, and available treatments, as well as present future perspectives toward more profound elucidation of the pathogenesis of ROP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811158      PMCID: PMC2929716          DOI: 10.1172/JCI42142

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  147 in total

1.  Prostaglandin biosynthesis can be triggered by lipid peroxides.

Authors:  M E Hemler; H W Cook; W E Lands
Journal:  Arch Biochem Biophys       Date:  1979-04-01       Impact factor: 4.013

2.  Mechanisms and biological consequences of nitrosative stress.

Authors:  Klaus-Dietrich Kröncke
Journal:  Biol Chem       Date:  2003 Oct-Nov       Impact factor: 3.915

Review 3.  Cellular mechanisms in retinal vascular development.

Authors:  Ray F Gariano
Journal:  Prog Retin Eye Res       Date:  2003-05       Impact factor: 21.198

Review 4.  A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis.

Authors:  Michael Klagsbrun; Anne Eichmann
Journal:  Cytokine Growth Factor Rev       Date:  2005 Aug-Oct       Impact factor: 7.638

5.  Retinal vascular development in premature infants.

Authors:  A M Roth
Journal:  Am J Ophthalmol       Date:  1977-11       Impact factor: 5.258

6.  Differential response in the release of hydrogen peroxide between astroglial cells and endothelial cells following hypoxia/reoxygenation.

Authors:  T Kondo; H Kinouchi; M Kawase; T Yoshimoto
Journal:  Neurosci Lett       Date:  1996-09-06       Impact factor: 3.046

7.  PGE(2)-mediated eNOS induction in prolonged hypercapnia.

Authors:  Daniella Checchin; Xin Hou; Pierre Hardy; Daniel Abran; Taline Najarian; Martin H Beauchamp; Sylvie G Bernier; Fernand Gobeil; Christiane Quiniou; Daya R Varma; Sylvain Chemtob
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

8.  Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes.

Authors:  J D Morrow; T A Minton; C R Mukundan; M D Campbell; W E Zackert; V C Daniel; K F Badr; I A Blair; L J Roberts
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

9.  Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.

Authors:  Martin Hervé Beauchamp; Anne Marilise Marrache; Xin Hou; Fernand Gobeil; Sylvie G Bernier; Pierre Lachapelle; Daniel Abran; Christiane Quiniou; Sonia Brault; Krishna G Peri; Jackson Roberts; Guillermina Almazan; Daya R Varma; Sylvain Chemtob
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-10       Impact factor: 4.799

10.  Alpha tocopherol decreases lipid peroxidation, neuronal necrosis, and reactive gliosis in reaggregate cultures of fetal rat brain.

Authors:  M Halks-Miller; M Henderson; L F Eng
Journal:  J Neuropathol Exp Neurol       Date:  1986-07       Impact factor: 3.685

View more
  92 in total

1.  An eye for discovery.

Authors:  Andreas Stahl; Lois E H Smith
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

2.  Ferrochelatase regulates retinal neovascularization.

Authors:  Sardar Pasha Sheik Pran Babu; Darcy White; Timothy W Corson
Journal:  FASEB J       Date:  2020-07-27       Impact factor: 5.191

3.  Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial.

Authors:  Andreas Stahl; Tim U Krohne; Nicole Eter; Isabel Oberacher-Velten; Rainer Guthoff; Synke Meltendorf; Oliver Ehrt; Sabine Aisenbrey; Johann Roider; Heinrich Gerding; Claudia Jandeck; Lois E H Smith; Johanna M Walz
Journal:  JAMA Pediatr       Date:  2018-03-01       Impact factor: 16.193

4.  Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.

Authors:  Mingjun Shi; Brianna Flores; Peng Li; Nancy Gillings; Kathryn L McMillan; Jianfeng Ye; Lily Jun-Shen Huang; Sachdev S Sidhu; Yong-Ping Zhong; Maria T Grompe; Philip R Streeter; Orson W Moe; Ming Chang Hu
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

Review 5.  Animal models of ocular angiogenesis: from development to pathologies.

Authors:  Chi-Hsiu Liu; Zhongxiao Wang; Ye Sun; Jing Chen
Journal:  FASEB J       Date:  2017-07-24       Impact factor: 5.191

6.  Relationship between mean platelet volume and retinopathy of prematurity.

Authors:  Yuan Tao; Yu Dong; Cheng-Wei Lu; Wei Yang; Qian Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-08       Impact factor: 3.117

7.  The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies.

Authors:  Jennifer L Wilkinson-Berka; Devy Deliyanti
Journal:  Ann Transl Med       Date:  2016-10

8.  Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.

Authors:  Justine R Smith; Larry L David; Binoy Appukuttan; Phillip A Wilmarth
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

9.  Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.

Authors:  Byung-Hak Kim; Junyeop Lee; Jun-Sub Choi; Dae Young Park; Ho Young Song; Tae Kyo Park; Chung-Hyun Cho; Sang-Kyu Ye; Choun-Ki Joo; Gou Young Koh; Tae-Yoon Kim
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

10.  The potential of nanomedicine therapies to treat neovascular disease in the retina.

Authors:  Krysten M Farjo; Jian-Xing Ma
Journal:  J Angiogenes Res       Date:  2010-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.